Associate Professor Susan Harden works as a Consultant Radiation Oncologist at the Peter MacCallum Cancer Centre and is a senior research fellow for the Cancer Registries Research Programme at Monash University. She qualified in medicine from Oxford University and completed her specialist training in Cambridge, UK, where she worked as a consultant from 2006-2019.

She was awarded a Doctorate in Medicine for her 2 years of translational research undertaken at the Johns Hopkins University Hospital, Baltimore, USA, focusing on the low-level molecular detection of lung, prostate and head and neck cancers 2000-2002. She was clinical lead for Public Health England’s National Disease Registry (Radiotherapy Dataset) 2017-2019 and the UK National Lung Cancer Audit and UK National Mesothelioma Audit from 2016-2020. She was a clinical oncology examiner for the UK Royal College of Radiologists 2017-2019.

Her current research interests are translational and radiotherapy trials for lung cancer, stereotactic ablative body radiotherapy (SABR), combined modality therapy and utilising national quality cancer registry datasets to highlight and address variation in clinical outcome. She is a current member of the RANZCR Quality Improvement Committee, the Trans Tasman Radiation Oncology Group (TROG), Thoracic Oncology Group Australia (TOGA), International Mesothelioma Interest Group (iMig), International Thymic Malignancy Interest Group (ITMIG), European Society for Radiotherapy and Oncology (ESTRO), American Society for Radiation Oncology (ASTRO) and International Association for the Study of Lung Cancer (IASLC).